We describe here an antigen marker, designated VE-I, that is detected early in gastrulation (-E6.5 through -E7.25) in the anterior visceral endoderm overlying the embryonic ectoderm opposite the primitive streak. The antibody-positive domain extends from the embryonic-extraembryonic junction to the distal tip of the embryo, and laterally around -one-third of the circumference of the egg cylinder. Analysis of embryos at earlier stages indicates that VE-1 is first expressed shortly after implantation, at -E5.0, in the visceral endoderm on one side of the embryo and thus is the earliest molecular marker of A-P asymmetry in the postimplantation mouse embryo described to date. Although VE-1 was detected with a polyclonal antiserum raised against a 24 amino acid polypeptide sequence of FGF2, we provide evidence that the VE-1 antigen is not FGF2. The data reported here are the first to provide molecular evidence that A-P polarity in the mouse embryo is established by E5.0 and that the visceral endoderm has A-P polarity.
Introduction
Establishment of the body axes is a fundamental step in early embryogenesis. In many organisms, including flies, worms and amphibians, molecules present in the unfertilized egg play a key role in this process (Davidson, 1990 ). In mammals, however, the mechanism of establishment of the dorsal-ventral (D-V) and anteriorposterior (A-P) axes is not understood, but maternallyderived information does not appear to be involved. Instead, the molecules that regulate axis formation are produced by the embryonic genome. There has been much speculation about when the axes are first specified in mammals and what types of cues prompt embryonic cells to activate the process of axis specification.
Following fertilization, the mouse embryo develops as an apparently symmetric, solid sphere of cells until * Corresponding author. blastocyst formation, when the inner cell mass (KM), which contains the progenitors of all the fetal tissues, becomes localized on one side of the blastocoel, thereby generating the first readily detectable manifestation of embryo asymmetry. At this stage, an axis can be drawn through the blastocyst, with one pole (the embryonic pole) being defined as the side of the blastocyst on which the ICM is located, and the other (the abembryonic pole) being defined as the side opposite the KM. This axis subsequently corresponds to the D-V axis of the nascent fetus. Thus it appears that asymmetry reflective of D-V axis specification is generated by the time the blastocyst has formed, presumably as a consequence of processes set in motion prior to or early in blastocyst formation.
In contrast, morphological asymmetry along the A-P axis does not become readily apparent until embryonic day 6.5 (E6.5) to E6.75, two days after the blastocyst has implanted, by which time gastrulation has begun 0925-4773/95/$09.50 0 1995 Elsevier Science Ireland Ltd. All rights reserved SSDI 0925-4773(94)00308-A and the presence of the primitive streak marks the observed that polyclonal antiserum 773 (Gonzalez et al., posterior pole of the A-P axis. Although morphological 1990) consistently stains a subdomain of the visceral manifestations of streak formation are not apparent endoderm of the mouse embryo. In embryos at the miduntil -E6.5, it is likely that the processes that determine streak stage of gastrulation (E7.0), this antiserum was the location of the streak, and hence the orientation of found to weakly stain the visceral endoderm cells overlythe A-P axis, are initiated earlier in development. As yet, ing the embryonic ectoderm opposite the primitive nothing is known about the mechanism of A-P speciticastreak ( Fig. 1B and C) . Thus the labelled cells are tion in the mouse. However, experimental studies in the localized on the anterior side of the embryo. The proxchick have suggested that the A-P axis may be induced imal limit of staining is at the embryonic-extrain the epiblast (primitive ectoderm) by interaction with embryonic junction and the antibody-positive domain an extraembryonic tissue, the hypoblast (Azar and Eyal- extends to the distal tip of the embryo (Fig. 1 B) . LateralGiladi, 1979) . In the mouse, the tissue most likely to be ly, only visceral endoderm cells directly overlying the analogous to the chick hypoblast is the visceral enectoderm, and not separated from it by the mesoderm doderm, an extraembryonic tissue that arises from the migrating out of the streak, are stained by the antiserum outermost cells of the ICM just prior to implantation (Fig. 1C) . Antibody staining was not detected in late and which covers the surface of the epiblast (the primistreak embryos (E7.5) in which the mesoderm has tive ectoderm derived from the inner cells of the ICM) migrated over the entire surface of the embryonic ectoduring the early post-implantation period of dederm, thereby separating it from the overlying visceral velopment.
endoderm (data not shown). A prerequisite to understanding the mechanism of A-P axis specification is to determine when it first occurs. On the basis of an analysis of sections of implanting mouse blastocysts and later stage embryos, Smith (1980 Smith ( , 1985 proposed that by the time of implantation (-E4.5) the blastocyst contains a three-dimensional system of positional information that eventually leads to the localization of its D-V and A-P axes. Recently, Gardner et al. (1992) have concluded that the plane, but not the polarity, of the A-P axis of the fetus may be specified in the implanting blastocyst; the polarity of this axis may not be specified until a later stage in early post-implantation development. As yet, the expression of molecular markers reflective of A-P polarity has not been detected prior to or immediately after implantation, leaving open the question of precisely when A-P polarity is specified. The earliest molecular marker of A-P polarity in the mouse embryo known to date is F', which is detected at -E5.5 in the embryonic ectoderm on the prospective posterior side of the embryo (Crossley and Martin, in press) .
In this paper, we describe a new marker designated VE-1 (Visceral Endodem-1) which is expressed in a subdomain of the visceral endoderm on the prospective anterior side of the early post-implantation mouse embryo, beginning at -E5.0. This asymmetric expression makes VE-1 the earliest indicator of presumed A-P polarity described thus far. Additionally, our data indicate that such axial information is present in the visceral endoderm, consistent with a role for that tissue in A-P patterning of the embryo.
To determine when antibody staining is first detectable, we examined embryos at progressively earlier stages of development. Antibody-positive cells were detected in all E6.5 embryos examined. As in older embryos, we found that the antibody-positive region is limited to a subdomain of the visceral endoderm extending from the extraembryonic-embryonic junction to the distal tip of the egg cylinder and is localized on one side of the embryo (Fig. 1D and E ), but at this stage staining is more intense than at E7.0. From an examination of transverse sections of those E6.5 embryos in which the site of the primitive streak could be discerned, it was evident that, as in older embryos, the antibody-positive cells are found on the anterior side of the embryo (data not shown). Data from transverse sections also showed that the antibody-positive cells extend around approximately one-third of the circumference of the embryo and that the boundary between antibody-positive and negative cells is very sharp (Fig 1E) . At this stage, antibody staining is clearly concentrated near the surface of the visceral endoderm cells. Antibody staining localized to one side of the embryo was also observed at E6.0 and E5.5 (data not shown).
Results .?.I. Detection of an anteriorly-localized epitope in the early post-implantation embryo
In the course of an immunohistochemical examination of early post-implantation mouse embryos, we Antibody staining was also detectable in embryos at -E5.0, shortly after implantation, although it was found to be much less intense than in embryos at E6.5. As in older embryos, it is limited to visceral endoderm cells localized on one side of the embryo. However, at this stage, the antibody-positive cells were found to overlie not only the embryonic ectoderm but also the extraembryonic ectoderm (Fig. 1F) . In many cells, the staining appeared to be localized in the apical cytoplasm, however, in other cells, staining was detected throughout the cytoplasm. No antibody-positive cells could be detected in recently implanted embryos at E4.5 (data not shown), suggesting that the epitope(s) detected by antiserum 773 in the early post-implantation embryo is first expressed shortly after implantation. 
Characterization of the epitope detected by antiserum 773 in the ear/y post-implantation embryo
Antiserum 773 was raised against polypeptide encoding amino acids l-24 of mature bovine FGF2 (basic Fibroblast Growth Factor), a sequence not conserved in other members of the FGF family (Gonzalez et al., 1990 ). Although we also tested two other anti-FGF2 antisera (see Experimental procedures), staining of early post-implantation mouse embryos was detected only with antiserum 773 (data not shown). This suggests that the epitope detected with this particular antiserum in early post-implantation embryos is not FGF2, but an antigen recognized by other antibodies present in the antiserum. To explore this possibility, we depleted serum 773 of antibodies against FGF2 by passing it through a column containing FGF2 coupled to Affigel. The absence of FGF2 antibodies in the treated serum was demonstrated by comparing the staining pattern detected in sections of E16.5 mouse embryos using mock-treated antiserum ( Fig. 2A) with that observed using the depleted antiserum (Fig. 2B) . Consistent with what has previously been described in the rat (Gonzalez et al., 1990) , the mock-treated serum stained a variety of tissues in the late gestation mouse embryo. In contrast, no staining was detectable with the treated serum. When the depleted serum was used to stain sections of embryos at E6.5, we observed a pattern of staining similar to that obtained with the untreated serum ( Fig. 2C and D) . From these data, we conclude that the epitope(s) detected by antiserum 773 in the early post-implantation embryo is not FGF2 but an as yet unknown molecule that we have provisionally named VE-1 (Visceral Endoderm-1).
Discussion
We describe here the detection of VE-1, an antigen marker that is localized to the anterior visceral endoderm during the early stages of gastrulation (-E6.5--E7.25).
The observation that VE-1 is detected on one side of the embryo as early as E5.0 suggests that it is the earliest molecular marker of A-P asymmetry in the post-implantation mouse embryo known to date. Its pattern of expression suggests that the A-P axis is specified by E5.0, consistent with Smith's hypothesis that by the blastocyst stage the embryo already contains the positional information that leads to establishment of the three embryonic axes (Smith, 1980; 1985) . The observation that VE-1 is localized in a subdomain of the embryonic visceral endoderm contrasts with data showing the broad distribution of other visceral endoderm-specific markers such as villin (Ezzell et al., 1989) and TGF-02 @lager et al., 1991) which are expressed throughout the embryonic and extraembryonic visceral endoderm, and cY-fetoprotein (AFP), which is expressed throughout the embryonic visceral endoderm (Dziadek and Andrews, 1983) . Thus, our data showing that VE-1 expression is localized to the anterior visceral embryonic endoderm are the first to provide evidence that the visceral endoderm has A-P polarity.
Just prior to gastrulation (E6.5) the VE-1 expression domain has sharp boundaries; it extends distally from the embryonic-extraembryonic junction to the distal tip of the egg cylinder and laterally around approximately one third of the circumference of the embryo, including the anterior midline. Although the proximal limit of VE-1 expression is coincident with the border between two morphologically distinct tissues of different lineages, the embryonic and extraembryonic ectoderms, the lateral and distal VE-1 expression limits do not correspond to any morphological features or obvious fate map boundaries in either in the underlying embryonic ectoderm or in the visceral endoderm itself. Cells within the VE-1 domain contribute to the endoderm of the anterior yolk sac and the foregut (Lawson et al., 1986; Lawson and Pedersen, 1987; P. Tam, personal communication) . The anterior embryonic ectoderm underlying the VE-lpositive visceral endoderm gives rise to neuroectoderm. anterior amnion, as well as some mesoderm (Snow, 1981; Tam, 1989; Lawson et al., 1991) .
An interesting question is how the VE-1 expression domain is established and maintained. Initially, VE-1 is detected in the visceral endoderm overlying both the extraembryonic and embryonic ectoderms. The subsequent restriction of VE-1 expression to the embryonic portion of the egg cylinder may be achieved by interactions between the visceral endoderm and the underlying embryonic and extraembryonic ectoderms. Such interactions have been shown to regulate the expression of another visceral endoderm-specific molecule, AFP (Dziadek, 1978) . When embryonic visceral endoderm is isolated and cultured in vitro, it expresses AFP, as it does in vivo. However, when the same embryonic visceral endoderm is co-cultured in contact with extraembryonic ectoderm, it does not express AFP. These observations suggest that the restriction of AFP expression to the embryonic visceral endoderm prior to E7.5 is due to inhibitory signals from the extraembryonic ectoderm (Dziadek and Andrews, 1983) . It is possible that a similar mechanism operates to limit the expression of VE-1 to the visceral endoderm overlying the embryonic ectoderm.
As yet, the identity of the VE-1 molecule is unknown. The antiserum used in this study was originally raised against a polypeptide sequence in the FGF2 protein, but we have provided evidence that VE-1 is not FGF2. Preliminary experiments indicate that VE-1 is resistant to treatments that would alter many carbohydrate moieties and that it is sensitive to proteases. Obviously, it will not be possible to determine the function of VE-1 until it is identified and experiments can be performed to ablate or alter its expression in vivo. Nevertheless, several aspects of its temporal and spatial distribution are suggestive of a possible function. When it is most abundant, VE-1 is only present in the visceral endoderm in contact with the embryonic ectoderm Moreover, VE-1 is localized near the surface of the visceral endoderm cells. These observations raise the possibility that it is involved in communication between the visceral endoderm and the embryonic ectoderm prior to and during the early stages of gastrulation. This is particularly intriguing in view of data suggesting that in the chick the analogous tissue, the hypoblast, appears to play a role in inducing the embryonic axis (Azar and Eyal-Giladi, 1979) . To date, the embryological manipulations required to determine if the mouse visceral endoderm contains axis-inducing molecules have not been feasible. However, if the visceral endoderm in the mouse does play a role in inducing the A-P axis, then an interesting possibility rais-ed by the data described here is that VE-1 may play a role in mediating this inductive interaction.
Materials and methods
Embryos were obtained from random-bred Swiss Webster mice (Simenson Laboratories, Gilroy, CA). Noon of the day on which the copulation plug was detected was considered to be 0.5 days of gestation (E0.5), although some variation was observed in developmental stage both between and within litters at the given embryonic ages. Early post-implantation embryos in their decidua and El65 embryos were fixed in formaldehyde: ethanol: acetic acid (913: 1). Following fixation, the embryos were dehydrated, embedded in paraffin wax and sectioned (6 pm). Sections were dewaxed, bleached in methanol containing 0.3% Hz02 and rehydrated.
For antibody staining, the embryo sections were pretreated for 30 min with 1.5% goat serum (Sigma) in phosphate buffered saline (PBS) and then incubated overnight at 4°C with antibodies diluted in PBS containing 5% BSA and 0.3% Triton X-100 (PBT) to a concentration of total immunoglobulins between 2.5 pglml and 5 &ml. The sections were then washed with cold PBS containing 0.3% Triton X-100 (PT) and treated for 1 h at room temperature with a goat anti-rabbit antibody coupled to horse radish peroxidase (Jackson Immunoresearch Laboratories, West Grove, PA) diluted 1:200 in PBT. Following several washes in PT, the sections were treated with 0.5 mg/ml of diaminobenzidine (Sigma) prepared in Tris-buffered saline, pH 7.6, and containing 0.01% hydrogen peroxide. The sections were washed, dehydrated, cleared, mounted and viewed in a Zeiss Axiophot photomicroscope.
The rabbit anti-FGF2 antisera used in this study were: 773 raised against a peptide comprised of amino acids l-24 of mature bovine FGF2 conjugated to BSA (kindly provided by Dr. Andrew Baird), CAT 7 raised against FGF2 isolated from bovine brain (kindly provided by Dr. Denis Gospodarowicz) and a serum raised against amino acids IO3-120 of mature FGF2 conjugated to KLH (kindly provided by Dr. Lewis T. Williams). Immunoglobulins were purified from each serum by affinity chromatography with Protein-A Sepharose (Pharmacia). To specifically remove anti-FGF2 antibodies from serum 773, a FGF2 affinity matrix was prepared by cross-linking bovine FGF2 (a gift of Dr. D. Gospodarowicz) to Affigel-10 (Biorad) following the manufacturer's protocol, A mock absorption matrix was prepared by cross-linking BSA to Affigel-10. Antibodies at working concentrations were passed repeatedly over the affigel-conjugate columns before application to tissue sections.
